These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 23222811)

  • 21. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1.
    Wei LQ; Li L; Lu C; Liu J; Chen Y; Wu H
    J Cell Physiol; 2019 Apr; 234(4):5153-5162. PubMed ID: 30362512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.
    Chang RM; Yang H; Fang F; Xu JF; Yang LY
    Hepatology; 2014 Oct; 60(4):1251-63. PubMed ID: 24825302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
    J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.
    Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b.
    Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM
    Liver Int; 2015 May; 35(5):1597-606. PubMed ID: 25424744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
    He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
    Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six2 is negatively correlated with prognosis and facilitates epithelial-mesenchymal transition via TGF-β/Smad signal pathway in hepatocellular carcinoma.
    Wan ZH; Ma YH; Jiang TY; Lin YK; Shi YY; Tan YX; Dong LW; Wang HY
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):525-531. PubMed ID: 31564506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1α expression and protein stability.
    Liu Y; Zhang JB; Qin Y; Wang W; Wei L; Teng Y; Guo L; Zhang B; Lin Z; Liu J; Ren ZG; Ye QH; Xie Y
    Hepatology; 2013 Aug; 58(2):692-705. PubMed ID: 23505027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of cell proliferation and metastasis of human hepatocellular carcinoma by miR-137 is regulated by CDC42.
    Gao M; Liu L; Li S; Zhang X; Chang Z; Zhang M
    Oncol Rep; 2015 Nov; 34(5):2523-32. PubMed ID: 26352279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients.
    Yuan B; Liang Y; Wang D; Luo F
    Cancer Sci; 2015 Jul; 106(7):819-24. PubMed ID: 25940592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition.
    Zhou Y; Li Y; Ye J; Jiang R; Yan H; Yang X; Liu Q; Zhang J
    Liver Int; 2013 Sep; 33(8):1271-80. PubMed ID: 23725476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma.
    Wu G; Wang Y; Lu X; He H; Liu H; Meng X; Xia S; Zheng K; Liu B
    BMC Cancer; 2015 Mar; 15():182. PubMed ID: 25880458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
    Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
    Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell.
    Zhou J; Wang W
    J Surg Oncol; 2011 Sep; 104(3):278-83. PubMed ID: 21495032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
    Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
    Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis.
    Wang J; Li J; Wang X; Zheng C; Ma W
    Biochem Biophys Res Commun; 2013 Sep; 439(1):47-53. PubMed ID: 23962428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
    Law PT; Ching AK; Chan AW; Wong QW; Wong CK; To KF; Wong N
    Carcinogenesis; 2012 Jun; 33(6):1134-41. PubMed ID: 22431718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection.
    Zhao YM; Zhou JM; Wang LR; He HW; Wang XL; Tao ZH; Sun HC; Wu WZ; Fan J; Tang ZY; Wang L
    Cancer; 2012 May; 118(10):2708-17. PubMed ID: 21989785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.